Literature DB >> 17715159

Mendelian randomization as an instrumental variable approach to causal inference.

Vanessa Didelez1, Nuala Sheehan.   

Abstract

In epidemiological research, the causal effect of a modifiable phenotype or exposure on a disease is often of public health interest. Randomized controlled trials to investigate this effect are not always possible and inferences based on observational data can be confounded. However, if we know of a gene closely linked to the phenotype without direct effect on the disease, it can often be reasonably assumed that the gene is not itself associated with any confounding factors - a phenomenon called Mendelian randomization. These properties define an instrumental variable and allow estimation of the causal effect, despite the confounding, under certain model restrictions. In this paper, we present a formal framework for causal inference based on Mendelian randomization and suggest using directed acyclic graphs to check model assumptions by visual inspection. This framework allows us to address limitations of the Mendelian randomization technique that have often been overlooked in the medical literature.

Mesh:

Year:  2007        PMID: 17715159     DOI: 10.1177/0962280206077743

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  254 in total

1.  A Bayesian approach for instrumental variable analysis with censored time-to-event outcome.

Authors:  Gang Li; Xuyang Lu
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

2.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.

Authors:  Brandon L Pierce; Habibul Ahsan; Tyler J Vanderweele
Journal:  Int J Epidemiol       Date:  2010-09-02       Impact factor: 7.196

3.  Causal effect of vitamin D on prostate cancer using Mendelian randomization approach.

Authors:  Haining Yu; Peng Xu; Yongchun Cui
Journal:  World J Urol       Date:  2015-08-21       Impact factor: 4.226

Review 4.  Methodological challenges in mendelian randomization.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen; Marilyn Cornelis; Peter Kraft
Journal:  Epidemiology       Date:  2014-05       Impact factor: 4.822

Review 5.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

6.  'Mendelian randomization' equals instrumental variable analysis with genetic instruments.

Authors:  George L Wehby; Robert L Ohsfeldt; Jeffrey C Murray
Journal:  Stat Med       Date:  2008-07-10       Impact factor: 2.373

7.  [Importance of modern genome-wide studies for the risk of myocardial infarction].

Authors:  T Kessler; J Erdmann; H Schunkert
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

8.  Bounded, efficient and multiply robust estimation of average treatment effects using instrumental variables.

Authors:  Linbo Wang; Eric Tchetgen Tchetgen
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2017-12-18       Impact factor: 4.488

9.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function.

Authors:  Kim Hughes; Tanya Flynn; Janak de Zoysa; Nicola Dalbeth; Tony R Merriman
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

10.  Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.

Authors:  Ying Zhu; Yongyue Wei; Ruyang Zhang; Xuesi Dong; Sipeng Shen; Yang Zhao; Jianling Bai; Demetrius Albanes; Neil E Caporaso; Maria Teresa Landi; Bin Zhu; Stephen J Chanock; Fangyi Gu; Stephen Lam; Ming-Sound Tsao; Frances A Shepherd; Adonina Tardon; Ana Fernández-Somoano; Guillermo Fernandez-Tardon; Chu Chen; Matthew J Barnett; Jennifer Doherty; Stig E Bojesen; Mattias Johansson; Paul Brennan; James D McKay; Robert Carreras-Torres; Thomas Muley; Angela Risch; Heunz-Erich Wichmann; Heike Bickeboeller; Albert Rosenberger; Gad Rennert; Walid Saliba; Susanne M Arnold; John K Field; Michael P A Davies; Michael W Marcus; Xifeng Wu; Yuanqing Ye; Loic Le Marchand; Lynne R Wilkens; Olle Melander; Jonas Manjer; Hans Brunnström; Rayjean J Hung; Geoffrey Liu; Yonathan Brhane; Linda Kachuri; Angeline S Andrew; Eric J Duell; Lambertus A Kiemeney; Erik Hfm van der Heijden; Aage Haugen; Shanbeh Zienolddiny; Vidar Skaug; Kjell Grankvist; Mikael Johansson; Penella J Woll; Angela Cox; Fiona Taylor; Dawn M Teare; Philip Lazarus; Matthew B Schabath; Melinda C Aldrich; Richard S Houlston; John McLaughlin; Victoria L Stevens; Hongbing Shen; Zhibin Hu; Juncheng Dai; Christopher I Amos; Younghun Han; Dakai Zhu; Gary E Goodman; Feng Chen; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.